These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2865601)

  • 21. HTLV-III antibody in Sydney homosexual men.
    Robertson PW; Young PS
    Med J Aust; 1985 Sep; 143(6):261. PubMed ID: 2993831
    [No Abstract]   [Full Text] [Related]  

  • 22. Transmission of HTLV-II.
    Chorba T
    JAMA; 1986 Dec; 256(22):3094. PubMed ID: 2878093
    [No Abstract]   [Full Text] [Related]  

  • 23. HTLV-III seropositivity in 1971-1972 parenteral drug abusers--a case of false positives or evidence of viral exposure?
    Moore JD; Cone EJ; Alexander SS
    N Engl J Med; 1986 May; 314(21):1387-8. PubMed ID: 3010112
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chronic generalized lymphadenopathy with splenomegaly associated with HTLV-III virus antibodies].
    Mijović A; Stevanović G; Brkić S; Dimitrijević M; Rolović Z; Ruvidić R
    Srp Arh Celok Lek; 1986 Jan; 114(1):109-20. PubMed ID: 3014667
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of infections caused by AIDS and hepatitis B viruses in jailed people.
    Crovari P; Cassini U; Infante D; Guano F; Icardi GC; Auteri G; Di Ponzio A; Cuneo Crovari P
    Boll Ist Sieroter Milan; 1985; 64(5):367-70. PubMed ID: 3004543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to HTLV-III in Haitian immigrants in French Guiana.
    Gazzolo L; Gessain A; Robin Y; Robert-Guroff M; de-Thé G
    N Engl J Med; 1984 Nov; 311(19):1252-3. PubMed ID: 6092952
    [No Abstract]   [Full Text] [Related]  

  • 27. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyoderma gangrenosum in a patient with HTLV-III antibody.
    Schwartz BK; Clendenning WE; Blasik LG
    Arch Dermatol; 1986 May; 122(5):508-9. PubMed ID: 3010887
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of evidence of HTLV-III endemicity in southern Africa.
    Lyons SF; Schoub BD; McGillivray GM; Sher R; Dos Santos L
    N Engl J Med; 1985 May; 312(19):1257-8. PubMed ID: 2985989
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.
    Schüpbach J; Haller O; Vogt M; Lüthy R; Joller H; Oelz O; Popovic M; Sarngadharan MG; Gallo RC
    N Engl J Med; 1985 Jan; 312(5):265-70. PubMed ID: 2981407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Etiology of acquired immunodeficiency syndrome].
    Odiseev Kh
    Vutr Boles; 1985; 24(2):7-9. PubMed ID: 2994303
    [No Abstract]   [Full Text] [Related]  

  • 32. Occurrence of anti-HTLV-III antibodies in Danish high-risk homosexuals in 1982-83--seroconversion rate and risk of AIDS.
    Hofmann B; Platz P; Odum N; Ryder LP; Svejgaard A; Pedersen NS; Nielsen JO; Faber V; Sprechler HH; Oehlenschlager J
    AIDS Res; 1986 Feb; 2(1):1-3. PubMed ID: 3013217
    [No Abstract]   [Full Text] [Related]  

  • 33. Screening for HTLV-III antibodies: the relation between prevalence and positive predictive value and its social consequences.
    JAMA; 1985 Jun; 253(23):3395-8. PubMed ID: 2987557
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
    Allain JP
    N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
    [No Abstract]   [Full Text] [Related]  

  • 35. [HTLV-III infections and AIDS--current epidemiology and serology].
    Biberfeld G; Böttiger M; Biberfeld P
    Lakartidningen; 1985 May; 82(20):1867-70. PubMed ID: 2987632
    [No Abstract]   [Full Text] [Related]  

  • 36. AIDS in an Italian drug addict.
    Lazzarin A; Parravicini CL; Meola G; Moroni M
    Lancet; 1984 Nov; 2(8412):1155. PubMed ID: 6150209
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV antibodies in intravenous drug abusers.
    Wodak A; Gold J
    Med J Aust; 1986 Sep; 145(6):298. PubMed ID: 3018463
    [No Abstract]   [Full Text] [Related]  

  • 38. Lack of correlation between promiscuity and seropositivity to HTLV-III from a low-incidence area for AIDS.
    Calabrese LH; Proffitt MR; Rehm S; Lederman M; Carey JT; Houser HB; Edmonds K; Ellner JJ
    N Engl J Med; 1985 May; 312(19):1256-7. PubMed ID: 2985988
    [No Abstract]   [Full Text] [Related]  

  • 39. Seroepidemiologic screening for antibodies to LAV/HTLV-III in Sri Lanka, 1980-1982.
    Miller RA; Collier AC; Buchanan TM; Handsfield HH
    N Engl J Med; 1985 Nov; 313(21):1352-3. PubMed ID: 2997608
    [No Abstract]   [Full Text] [Related]  

  • 40. HTLV-III seroconversion in a homosexual patient with common variable immunodeficiency.
    Morell A; Barandun S; Locher G
    N Engl J Med; 1986 Aug; 315(7):456-7. PubMed ID: 3016539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.